Cytokeratin 19 fragments in patients with acute lung injury: a preliminary observation.
OBJECTIVE
Cytokeratin 19 (CK19) is a specific cytoskeletal structure for alveolar epithelium. We hypothesized that the levels of CK19 fragments in bronchoalveolar lavage (BAL) fluid could serve as an index of epithelial injury and as a prognosis marker in patients with acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). The aims of our study were, in patients with ALI/ARDS: (1) to measure CK19 fragments concentrations in BAL fluid, (2) to assess its prognostic value, and (3) to identify the cellular source of CK19 in the alveolar space.


METHODS
Prospective preliminary study.


METHODS
University hospital surgical ICU.


METHODS
Twenty-two mechanically ventilated patients with ALI/ARDS and 10 non-ventilated control patients. Plasma samples were obtained for 11 ALI/ARDS patients.


RESULTS
The concentration of BAL CK19 fragments was higher in patients (median 4916 pg/ml, 25th-75th percentile 2717-10533) than in controls (2208 pg/ml. 767-3923; p =0.05), and higher in 10 non-survivors (7051 pg/ml, 4372-13371) than in 12 survivors (2888 pg/ml, 1315-5639; p =0.03 among ALI/ARDS patients). BAL CK19 fragment concentration did not correlate with simplified acute physiologic score, lung injury score or PaO(2)/FIO(2) ratio, but correlated positively with BAL albumin concentration (p =0.002) and with number of BAL macrophages (p=0.0001). Plasma CK19 fragment concentrations were 10 times lower than those in BAL. Immunohistochemical staining for CK19 showed a strong labelling of injured detached epithelial cells and hyperplastic epithelium in ALI/ARDS lung samples.


CONCLUSIONS
CK19 fragment concentrations were found to be elevated in BAL fluid in ALI/ARDS patients compared with control subjects. High BAL CK19 fragment levels were associated with a poor prognosis.
Stern
Jean-Baptiste
JB
Institut Mutualiste Montsouris, Département Thoracique, 42 bd Jourdan, 75014 Paris, France. jean-baptiste.stern@imm.fr
Paugam
Catherine
C
Validire
Pierre
P
Adle-Biassette
Homa
H
Jaffré
Sandrine
S
Dehoux
Monique
M
Crestani
Bruno
B
D001992:Bronchoalveolar Lavage Fluid; D005602:France; D006801:Humans; D053539:Keratin-19 / Q000032:analysis*; D011446:Prospective Studies; D012128:Respiratory Distress Syndrome / Q000175:diagnosis* / Q000503:physiopathology
D053539:Keratin-19